Albany Molecular Research, Inc. (NASDAQ:AMRI)
CAPS Rating:
The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market.
RSS Headlines
Fool UK
Recs
Strong company, recent run up on no news suggest good news coming.